Prognostic impact of treatment modalities on patients with single nodular recurrence of hepatocellular carcinoma

Masaki Ueno; Kazuhisa Uchiyama; Satoru Ozawa; Takayuki Nakase; Naoki Togo; Shinya Hayami; Hiroki Yamaue
August 2009
Surgery Today;Aug2009, Vol. 39 Issue 8, p675
Academic Journal
Abstract Purpose  To evaluate the prognostic impact of various therapeutic modalities, such as repeat hepatectomy, ablation therapy, and transcatheter arterial chemoembolization (TACE) therapy, used to treat single nodular recurrent hepatocellular carcinoma (HCC). Methods  Thirty-two patients with single nodular intrahepatic recurrence after curative primary resection of HCC were enrolled in this study. The prognostic factors after recurrence were established using 13 clinicopathologic variables, including the therapeutic modalities; namely, repeat hepatectomy, ablation therapy, or TACE therapy. Results  Of the 32 patients, 9 underwent repeat hepatectomy, 10 underwent ablation therapy, and 13 underwent TACE therapy. The therapeutic modality was the only prognostic factor. In comparison with TACE therapy, the relative risks associated with ablation therapy and repeat hepatectomy were 0.19 and 0.29, respectively. The 5-year survival rates after single nodular recurrence were 57% in the ablation therapy group, 29% in the repeat hepatectomy group, and 0% in the TACE therapy group. Conclusions  Repeat hepatectomy and ablation therapy are more effective than TACE therapy for improving the prognosis of patients with single nodular intrahepatic recurrent HCC.


Related Articles

  • Appropriate treatment strategy for intrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Hirokawa, Fumitoshi; Hayashi, Michihiro; Miyamoto, Yoshiharu; Asakuma, Mitsuhiro; Shimizu, Tetsunosuke; Komeda, Koji; Inoue, Yoshihiro; Tanigawa, Nobuhiko // Journal of Gastrointestinal Surgery;Jul2011, Vol. 15 Issue 7, p1182 

    Introduction: The aim of this study is to evaluate the appropriate treatment for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (HCC).Methods: Of 151 patients who underwent initial hepatectomy for HCC, 82 had intrahepatic recurrence and were...

  • Clinicopathologic Characteristics and Long-Term Prognosis of Scirrhous Hepatocellular Carcinoma. Lee, Jin; Choi, Moon; Gwak, Geum; Lee, Joon; Koh, Kwang; Paik, Seung; Yoo, Byung; Choi, Dongil; Park, Cheol // Digestive Diseases & Sciences;Jun2012, Vol. 57 Issue 6, p1698 

    Background: Clinicopathologic features and long-term outcomes in patients with scirrhous hepatocellular carcinoma (S-HCC) are not fully defined. Methods: We compared data of 37 patients with S-HCC and 604 with usual HCC (U-HCC) undergoing surgery. Results: The S-HCC group showed less HBV...

  • Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria. Amano, Hironobu; Tashiro, Hirotaka; Oshita, Akihiko; Kobayashi, Tsuyoshi; Tanimoto, Yoshisato; Kuroda, Shintaro; Tazawa, Hirofumi; Itamoto, Toshiyuki; Asahara, Toshimasa; Ohdan, Hideki // Journal of Gastrointestinal Surgery;Jul2011, Vol. 15 Issue 7, p1173 

    Background: The appropriate treatment strategy for advanced hepatocellular carcinoma (HCC) that does not meet the Milan criteria (MC) is unclear. The aim of this study was to determine the significance of surgical treatment for such patients.Study Design: From January...

  • Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients. Ning, Su; Bin, Chen; Na, Huang; Peng, Shen; Yi, Ding; Xiang-hua, Ye; Fang-yin, Zeng; Da-yong, Zheng; Rong-cheng, Luo // Molecular Biology Reports;Jan2012, Vol. 39 Issue 1, p351 

    Metastasis/recurrence has been the most fundamental characteristic of hepatocellular cancer (HCC) and the ultimate cause of most HCC-related deaths. However, there are still a limited number of reliable tumor markers that can be used to predict the possibility of metastasis/recurrence in an HCC...

  • Co-Upregulation of 14-3-3ζ and P-Akt is Associated with Oncogenesis and Recurrence of Hepatocellular Carcinoma. Yufu Tang; Ruoyu Wang; Yibing Zhang; Shenhui Lin; Na Qiao; Zhongyi Sun; Shuqun Cheng // Cellular Physiology & Biochemistry (Karger AG);Feb2018, Vol. 45 Issue 3, p1097 

    Background/Aims: 14-3-3ζ is involved in the regulation of PI3K/Akt pathway which is closely associated with carcinogenesis. However, the clinical significance of combined detection of 14-3-3ζ and p-Akt in hepatocellular carcinoma (HCC) remains unclear. Methods: Two-hundred pairs of HCC and...

  • Malignant Mixed Müllerian Tumour of the Uterus: Analysis of 44 Cases. Grasso, Silvana; Loizzi, Vera; Minicucci, Valentina; Resta, Leonardo; Camporeale, anna Lina; Cicinelli, Ettore; Cormio, Gennaro // Oncology;Apr2017, Vol. 92 Issue 4, p197 

    Objectives: The aim of our study was to evaluate the clinicopathological features and prognostic factors of uterine carcinosarcoma. Patients and Methods: In this retrospective study, the clinical characteristics of 44 patients with uterine MMMT were evaluated. Survival curves were estimated by...

  • Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma. Kitano, Kentaro; Murayama, Tomonori; Sakamoto, Miki; Nagayama, Kazuhiro; Ueno, Katsuhito; Murakawa, Tomohiro; Nakajima, Jun // European Journal of Cardio-Thoracic Surgery;Feb2012, Vol. 41 Issue 2, p376 

    OBJECTIVE The lung is the most common site for extrahepatic metastasis from hepatocellular carcinoma (HCC). We previously reported in a series of 20 patients that pulmonary metastasectomy for HCC is feasible in selected patients. The objective of this study was to re-evaluate the long-term...

  • The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus. Komatsu, Shohei; Fukumoto, Takumi; Demizu, Yusuke; Miyawaki, Daisuke; Terashima, Kazuki; Niwa, Yasue; Mima, Masayuki; Fujii, Osamu; Sasaki, Ryohei; Yamada, Isamu; Hori, Yuichi; Hishikawa, Yoshio; Abe, Mitsuyuki; Ku, Yonson; Murakami, Masao // Journal of Gastroenterology;Jul2011, Vol. 46 Issue 7, p913 

    Background: The prognosis of patients who have hepatocellular carcinoma (HCC) associated with inferior vena cava tumor thrombus (IVCTT) is very poor, and effective treatment modalities are extremely limited. The objective of this study was to determine the therapeutic efficacy of particle...

  • Super-selection of a subgroup of hepatocellular carcinoma patients at minimal risk of recurrence for liver transplantation. Hwang, Shin; Ahn, Chul-Soo; Kim, Ki-Hun; Moon, Deok-Bog; Ha, Tae-Yong; Song, Gi-Won; Jung, Dong-Hwan; Park, Gil-Chun; Yu, Young-Dong; Park, Pyoung-Jae; Choi, Young-Il; Kim, Kyoung-Won; Lim, Young-Suk; Lee, Han; Yu, Eun-Sil; Lee, Sung-Gyu; Lee, Han Chu // Journal of Gastrointestinal Surgery;Jun2011, Vol. 15 Issue 6, p971 

    Background: A majority of patients with hepatocellular carcinoma (HCC) undergoing liver transplantation (LT) meet the Milan criteria, but these are still regarded as the narrowest criteria for transplantation. Prognostic analysis of incidentally detected HCC after LT suggests that a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics